BUFFALO, N.Y.--(BUSINESS WIRE)--Aug 7, 2018--Rand Capital Corporation (Nasdaq:RAND) (“Rand”), a venture capital company which invests in growth businesses with unique product, service or technology concepts, announced its results for the quarter and six months ended June 30, 2018.

Allen F. (“Pete”) Grum, President and Chief Executive Officer of Rand Capital, commented, “During the quarter we invested $775,000 in debt instruments supporting KnowledgeVision’s progression of its smart media technology. Since we first began investing in them in 2013, the company has increased its registered user base tenfold.”

Mr. Grum added, “We continue to work with the SBA to secure an additional $6 million of debentures. With a full pipeline of investment opportunities, we look forward to completing this transaction and putting the funds to work in support of exciting growth businesses.”

Second Quarter 2018 Financial Highlights

Reported $4.87 net asset value (NAV) per share at June 30, 2018, compared with $4.97 at March 31, 2018. The decrease was primarily due to write-downs of investments in certain portfolio companies based on their recent operating performance. Supported an existing portfolio company, KnowledgeVision ® Systems, Inc., with $775,000 of investments during the quarter. Investment income increased 18% and 15% over the prior-year second quarter and first six months, respectively. At June 30, 2018, portfolio fair value was $32.3 million and consolidated cash was $4.7 million.

Total investment income in the second quarter of 2018 grew to $413,000, up from $349,000 in the second quarter of 2017. The $64,000 increase was driven by the Company’s success with focusing on investments in income producing instruments. Total expenses in the 2018 and 2017 second quarters were $474,000 and $607,000, respectively, reflecting a reduction of 22%. The decrease is primarily due to lower professional fees, partially offset by higher bad debt expense.

Total investment income was $776,000 and $678,000 for the first six months ended June 30, 2018 and 2017, respectively. Similar to the second quarter, the growth was driven by the Company’s investment focus on income-generating instruments. Total expenses for the first six months of 2018 and 2017 were $1.1 million in each period.

Selected Portfolio Highlights

is a leader in smart media creation and hosting technology. Its Knovio ® video platform is used by more than 300,000 people worldwide in more than 2,000 companies and campuses to create, host, share, organize, collaborate around, and measure online media content. The company recently further strengthened its leadership position by winning its second U.S. patent for its video presentation technology, launching a groundbreaking live multimedia webcasting product, Knovio Live. Including its second quarter investments, at June 30, 2018, Rand’s investment in KnowledgeVision was valued at approximately $1.3 million. is a new high-value healthcare solution built specifically for employers and their employees and families. Centivo SM targets lowering healthcare costs and improved healthcare outcomes by rewarding members and providers for smart choices and actions while delivering an exceptional member experience. Centivo recently raised $34 million in Series A funding, in which Rand invested $200,000 and converted a $100,000 convertible note during the first quarter of 2018. The capital will be deployed to build the company’s technology and infrastructure, develop local partnerships, and support market launch. At June 30, 2018, Rand’s investment in Centivo was valued at approximately $301,000. is a developer of fully automated, sample-to-answer molecular testing solutions for use in multiple applications. Rheonix recently announced two new innovative products for use on the Encompass Optimum™ workstation. First, they expanded their Beer SpoilerAlert™ assay to detect more organisms that may cause spoilage in beer, resulting in the simplest and most comprehensive beer spoilage test in the market. Second, Rheonix launched the Listeria PatternAlert™ assay, a breakthrough method for rapidly identifying molecular patterns from Listeria strains. Its quick results enable food producers to take rapid action to reduce the risk of contamination and recall. In addition, the company has initiated clinical studies to gain FDA clearance for its Encompass MDx™ Workstation and the Rheonix STI Tri-Plex assay for the simultaneous detection of three sexually transmitted infections. At June 30, 2018, Rand’s investment in Rheonix was valued at approximately $2.9 million.

As of June 30, 2018, Rand’s portfolio consisted of 30 active companies. At that date, the portfolio was comprised of approximately 58% in equity investments and 42% in debt investments, compared with 59% in equity investments and 41% in debt investments at June 30, 2017.

Webcast and Conference Call

Rand will host a conference call and live webcast today, August 7, 2018, at 1:30 p.m. Eastern Time to review its financial condition and results for the 2018 second quarter, as well as its strategy and outlook. The review will be accompanied by a slide presentation, which will be available on Rand’s website at www.randcapital.com under the “Investor Relations” heading. A question-and-answer session will follow the formal presentation.

Rand’s conference call can be accessed by calling (201) 689-8263. Alternatively, the webcast can be monitored on Rand’s website at www.randcapital.com under the “Investor Relations” heading.

A telephonic replay will be available from approximately 4:30 p.m. Eastern Time today through Tuesday, August 14, 2018. To listen to the archived call, dial (412) 317-6671, and enter conference ID number 13681337. A transcript of the call will be placed on Rand’s website, once available.

ABOUT RAND CAPITAL

Rand Capital (Nasdaq: RAND) provides investors the ability to participate in venture capital opportunities through an investment in the Company’s stock. Rand is a Business Development Company (BDC) with a wholly owned subsidiary licensed by the U.S. Small Business Administration (SBA) as a Small Business Investment Company (SBIC). Rand focuses its equity investments in early or expansion stage companies and generally lends to more mature companies. The Company seeks investment opportunities in businesses with strong leaders who are bringing to market new or unique products, technologies or services that have a high potential for growth. Additional information can be found at the Company’s website where it regularly posts information: http://www.randcapital.com/.

Safe Harbor Statement

This news release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements concerning future net asset value growth, investment returns and opportunities as well as Rand’s plans for utilizing proceeds from sales of portfolio companies when and if received. These statements involve known and unknown risks, uncertainties and other factors that could cause the actual results to differ materially from the results expressed or implied by such statements, including general economic and business conditions, conditions affecting the portfolio companies’ markets, competitor responses, and market acceptance of their products and services and other factors disclosed in the Corporation’s periodic reports filed with the Securities and Exchange Commission. Consequently, such forward-looking statements should be regarded as the Corporation’s current plans, estimates and beliefs. The Corporation assumes no obligation to update the forward-looking information contained in this release.

FINANCIAL TABLES FOLLOW.

This article has been truncated. You can see the rest of this article by visiting http://www.businesswire.com/news/home/20180807005255/en.